U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07304349) titled 'Prospective Evaluation of Rapid Diagnostic Tests for Trypanosoma Cruzi Infection' on Dec. 12.
Brief Summary: Chagas disease (CD) is the most significant endemic zoonosis in Argentina. Two-thirds of affected individuals live in urban areas but only 10% globally are aware of their infection. Diagnosing Chronic Chagas (CCD) requires at least two serological tests, often limited to reference laboratories, creating logistical and economic challenges that delay timely diagnosis and treatment. Although primary health care (PHC) could address most health needs, the availability of Rapid Diagnostic Tests (RDTs) for CCD is limited in endemic ...